Skip to main content
. Author manuscript; available in PMC: 2013 Oct 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2012 Aug 18;264(2):262–273. doi: 10.1016/j.taap.2012.08.007

Figure 2.

Figure 2

TCDD-induced changes in microRNA expression observed with Exiqon LNA microarrays at 36 hpf (A) and 60 hpf (B). Data are expressed as percent change of expression normalized to the DMSO carrier control treatment. All of the changes in microRNAs plotted in this graph were statistically significant based on p-value <0.01. However only miR-218b was significant when using the Bonferroni correction (0.000196) to safeguard against false positives.